Accumulated Chromosomal Instability in Murine Bone Marrow Mesenchymal Stem Cells Leads to Malignant Transformation

¹ National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland
² National Cancer Institute, National Institutes of Health, Bethesda, Maryland
³ Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland

^* To whom correspondence should be addressed. E-mail: sshi{at}dir.nidcr.nih.gov.

	Abstract

Despite recent emerging evidences suggest that cancer stem cells subsist in a variety of tumors, it is not yet fully elucidated whether postnatal stem cells are directly involved in tumorigenesis. We used murine bone marrow-derived mesenchymal stem cells (BMMSCs) as a model to test a hypothesis that tumorigenesis may originate from spontaneous mutation of stem cells. In this study, we demonstrated that murine BMMSCs, after numerous passages, obtained unlimited population doublings and proceeded to a malignant transformation state, resulting in fibrosarcoma formation in vivo. Transformed BMMSCs colonized to multiple organs when delivered systemically through the tail vein. Fibrosarcoma cells formed by transformed BMMSCs contained cancer progenitors, which were capable of generating colony clusters in vitro and fibrosarcoma in vivo by the second administration. The mechanism by which BMMSCs transformed to malignant cells was associated with accumulated chromosomal abnormalities, gradual elevation in telomerase activity, and increased c-myc expression. Moreover, BMMSCs and their transformed counterpart, fibrosarcoma-forming cells, demonstrated different sensitivity to anticancer drugs. BMMSCs/fibrosarcoma transformation system may provide an ideal system to elucidate the mechanism of how stem cells become cancer cells and to screen anti-sarcoma drugs.

This article has been cited by other articles:

				I. B. Copland, E. M. Jolicoeur, M.-A. Gillis, J. Cuerquis, N. Eliopoulos, B. Annabi, A. Calderone, J.-F. Tanguay, A. Ducharme, and J. Galipeau Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties Cardiovasc Res, August 1, 2008; 79(3): 405 - 415. [Abstract] [Full Text] [PDF]

				E. Pawelczyk and J. A. Frank Transferrin Receptor Expression in Iron Oxide-labeled Mesenchymal Stem Cells Radiology, June 1, 2008; 247(3): 913 - 914. [Full Text] [PDF]

				G. Lazennec and C. Jorgensen Concise Review: Adult Multipotent Stromal Cells and Cancer: Risk or Benefit? Stem Cells, June 1, 2008; 26(6): 1387 - 1394. [Abstract] [Full Text] [PDF]

				E. Jones and D. McGonagle Human bone marrow mesenchymal stem cells in vivo Rheumatology, February 1, 2008; 47(2): 126 - 131. [Abstract] [Full Text] [PDF]

				H. Li, X. Fan, R. C. Kovi, Y. Jo, B. Moquin, R. Konz, C. Stoicov, E. Kurt-Jones, S. R. Grossman, S. Lyle, et al. Spontaneous Expression of Embryonic Factors and p53 Point Mutations in Aged Mesenchymal Stem Cells: A Model of Age-Related Tumorigenesis In Mice Cancer Res., November 15, 2007; 67(22): 10889 - 10898. [Abstract] [Full Text] [PDF]

				A. J. Nauta and W. E. Fibbe Immunomodulatory properties of mesenchymal stromal cells Blood, November 15, 2007; 110(10): 3499 - 3506. [Abstract] [Full Text] [PDF]

				M. E. Bernardo, N. Zaffaroni, F. Novara, A. M. Cometa, M. A. Avanzini, A. Moretta, D. Montagna, R. Maccario, R. Villa, M. G. Daidone, et al. Human Bone Marrow Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-term In vitro Culture and Do Not Exhibit Telomere Maintenance Mechanisms Cancer Res., October 1, 2007; 67(19): 9142 - 9149. [Abstract] [Full Text] [PDF]

				F. Locatelli, R. Maccario, and F. Frassoni Mesenchymal stromal cells, from indifferent spectators to principal actors. Are we going to witness a revolution in the scenario of allograft and immune-mediated disorders? Haematologica, July 1, 2007; 92(7): 872 - 877. [Full Text] [PDF]

				S. Aguilar, E. Nye, J. Chan, M. Loebinger, B. Spencer-Dene, N. Fisk, G. Stamp, D. Bonnet, and S. M. Janes Murine but Not Human Mesenchymal Stem Cells Generate Osteosarcoma-Like Lesions in the Lung Stem Cells, June 1, 2007; 25(6): 1586 - 1594. [Abstract] [Full Text] [PDF]

				K. Inoue, S. Noda, N. Ogonuki, H. Miki, S. Inoue, K. Katayama, K. Mekada, H. Miyoshi, and A. Ogura Differential Developmental Ability of Embryos Cloned from Tissue-Specific Stem Cells Stem Cells, May 1, 2007; 25(5): 1279 - 1285. [Abstract] [Full Text] [PDF]

				D. G. Katritsis, P. Sotiropoulou, E. Giazitzoglou, E. Karvouni, and M. Papamichail Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells Europace, March 1, 2007; 9(3): 167 - 171. [Abstract] [Full Text] [PDF]

				K. Chaichana, G. Zamora-Berridi, J. Camara-Quintana, and A. Quinones-Hinojosa Neurosphere Assays: Growth Factors and Hormone Differences in Tumor and Nontumor Studies Stem Cells, December 1, 2006; 24(12): 2851 - 2857. [Abstract] [Full Text] [PDF]

				C. B. Doering, B. Gangadharan, and H. T. Spencer Marrow-Derived Stromal Cells as Gene Transfer Vehicles in a Murine Model of Hemophilia A. Blood (ASH Annual Meeting Abstracts), November 16, 2006; 108(11): 5489 - 5489. [Abstract] [PDF]

				Y. F. Zhou, M. Bosch-Marce, H. Okuyama, B. Krishnamachary, H. Kimura, L. Zhang, D. L. Huso, and G. L. Semenza Spontaneous Transformation of Cultured Mouse Bone Marrow-Derived Stromal Cells. Cancer Res., November 15, 2006; 66(22): 10849 - 10854. [Abstract] [Full Text] [PDF]

				X. Wu, S. A. Estwick, S. Chen, M. Yu, W. Ming, T. D. Nebesio, Y. Li, J. Yuan, R. Kapur, D. Ingram, et al. Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells Hum. Mol. Genet., October 1, 2006; 15(19): 2837 - 2845. [Abstract] [Full Text] [PDF]